Fujinomiya City, Shizuoka: 'Metallo-Balance Test' for Cancer and Cognitive (MCI) Risk Assessment with Only 6mL Blood Sample Now Accepting Reservations at Fujimi Health Clinic Starting August

Renatech Inc. (headquartered in Isehara, Kanagawa Prefecture), a company that develops health indicators based on trace elements and applies them in real-world settings, announces the opening of reservation bookings for its proprietary screening test, the 'Metallo-Balance Test,' which evaluates risks for cancer and MCI (mild cognitive impairment). The test will be available at Fujimi Health Clinic (Fujinomiya City, Shizuoka Prefecture), a partner medical institution, with reservations now open for testing between August and November 2026.

With the establishment of a continuous testing system at this clinic, residents in the Fujinomiya area will have stable access to the Metallo-Balance Test, contributing as a practical option for personal health management and preventive care.

Renatech will continue to work with partner medical institutions nationwide to maintain and expand access, aiming to encourage more people to take interest in their health and reconsider daily habits as part of preventive healthcare.

What is the Metallo-Balance (MB) Test?

The Metallo-Balance Test is a risk screening (triage) test that objectively assesses an individual’s current risk for cancer and MCI (mild cognitive impairment) by analyzing the concentration balance of 17 trace elements (metal elements) in the blood.

### Key Features of the Test

- Single 6mL blood draw: Blood is safely collected under proper medical supervision. The test takes approximately 15 minutes, minimizing physical burden and ensuring safety.

- Site-specific 'Cancer Risk Test': With a single blood draw, cancer risk is evaluated by site—6 sites for men, 9 for women—and scored on a four-tier scale (A to D): - Men: Lung, stomach, liver, pancreatic, colorectal, and prostate cancer - Women: Lung, stomach, liver, pancreatic, colorectal, breast, cervical, endometrial, and ovarian cancer

- Comprehensive 'Cognitive Risk Test (MCI Risk Assessment)': Evaluates all types of cognitive decline, including Alzheimer’s, vascular, and Lewy body dementia.

- Proven research and international recognition: Developed with research funding from the Ministry of Economy, Trade and Industry’s Go-Tech program, in collaboration with the Kanagawa Cancer Center and Chiba Cancer Center. Patented in 9 countries including Japan, with over 100,000 test-takers cumulatively (from April 2019 to March 2026).

Testing Process and Key Pre-Test Instructions

※ Due to required document mailing procedures, advance registration is required approximately three weeks before the desired test date (fully appointment-based).

- Registration: Apply via website or phone. A complete set of test documents will be mailed to your home about one week before your appointment.

- Test Day (Blood Draw): Appointments ensure smooth blood collection (takes about 15 minutes). Payment is post-service, so no on-site payment is required.

- Results Notification: The invoice (payment slip) will be mailed to your home approximately three weeks after blood draw, and test results will follow about five weeks after.

### Key Pre-Test Instructions

- Food and Alcohol: No food after 9 PM the previous day. No alcohol consumption the day before. - Hydration: Drink plenty of water to facilitate blood draw. - Medications and Supplements: Over-the-counter drugs and supplements must be discontinued the day before. Prescription medications may be taken as usual.

Test Fees (Private-Pay Service)

This test is not covered by health insurance and is offered as a private-pay service. Choose from the following options:

- Cancer Risk Test: ¥19,800 (tax included) - Cognitive Risk Test: ¥19,800 (tax included) - Combined Cancer and Cognitive Risk Test: ¥24,200 (tax included)

※ Listed prices are standard rates. ※ Payment will be via 'DSK Postpay,' delivered to your home after blood draw. ※ Some medical institutions may not offer one or both tests.

Eligibility and Important Notes

### Age Requirements

- Cancer Risk Test: Japanese nationals aged 20 to 80 - Cognitive Risk Test: Japanese nationals aged 50 to 80

※ The test is developed based on data from Japanese individuals within these age ranges. Those outside this range or non-Japanese nationals may take the test, but results will be for reference only.

### Individuals Who Cannot Take the Test

- Pregnant individuals or those within 6 months postpartum - Currently undergoing cancer treatment or within 1 year of completing treatment - Receiving dialysis - Those with fractures, blood disorders, or immunodeficiency (excluding lipid disorders such as high triglycerides) - Individuals feeling unwell (e.g., sleep-deprived, after all-nighters, intense exercise, high stress, or symptoms of cold, asthma, shingles, allergic rashes, or rhinitis)

Partner Medical Institution Overview

- Testing Schedule: Twice monthly, on Mondays and Tuesdays (excluding holidays and clinic closures) - Institution Name: Fujimi Health Clinic - Address: 1296-11 Hina, Fujinomiya City, Shizuoka 417-0847 - Access: 10-minute walk from Gakunan Fujigaoka Station - Available Tests: Cancer Risk Test and Cognitive Risk Test

▼ Check Available Dates and Book Here Schedules for August to November, as well as updated future schedules from December onward, can be viewed and booked via the web reservation system below.

Metallo-Balance Test Web Reservation: https://metallo-balance.net/entry/

### How to Check Dates and Apply

- Visit the URL above and select 'General Public' (red button) - Choose your region under 'Find Test Site' (Chubu Region > Shizuoka Prefecture) - Select 'Fujimi Health Clinic' as the test site to view currently available dates. ※ Each testing slot has a limited capacity. Registration closes once full.

⚠️ Important Notice for Test-Takers (Please Read)

- Do not contact the medical institution directly: The clinic’s front desk or phone line cannot handle inquiries or bookings for this test. All inquiries and applications must be directed to Renatech.

- For more details and applications:

- Metallo-Balance Test Information Site: https://www.mbkensa.com/

- Toll-Free Hotline: 0120-785-602 (Renatech: Weekdays 9:00–17:00)

▼ Digital Brochure: Metallo-Balance Test

d182526-36-8374c9707ad17b046f8db55574016f94.pdf

🏥 Partner Medical Institutions Wanted Nationwide! For information on introducing the Metallo-Balance Test, visit:

Meet Metarona-chan, the official mascot of the Metallo-Balance Test

Renatech Inc. is an innovation company specializing in unique technology development in healthcare, wellness, and environmental fields, with a focus on early risk assessment for diseases like cancer. Recognized by Japan’s Ministry of Economy, Trade and Industry and the Small and Medium Enterprise Agency as one of the '300 Outstanding Growing SMEs and Small Businesses,' the company is nationally acknowledged for its technological excellence and social contribution.

Among its innovations, the 'Metallo-Balance Test' analyzes the concentration of 17 trace elements in the blood to assess cancer risk